quanthealth.aiCrawled Nov 2, 2026
The page describes virtual testing of clinical hypotheses to refine and optimize trial protocols.
Predictive, Competitive Positioning enables organizations to foresee clinical trial and commercial outcomes, integrating insights for smarter decisions in drug development and market strategy.
QuantHealth is trusted by the world's top biopharma to support their key clinical development decisions. With over 600 simulated trials, achieving up to 90% preditive accuracy, QuantHealth now has the industry's most advanced clinical trial simulation portfolio.
Allocate resources with greater certainty, powered by the best analytic and predictive platforms, not guesswork.
How AI Will Impact The Development of New Medicines
The page explains how AI and machine learning provide data-driven insights in clinical development.
The page covers mechanisms of action, clinical development stages, drug discovery, clinical simulations, trial design, and data.
QuantHealth is the global leader in AI-driven, clinical trial simulations.
The page describes how to identify, evaluate, and transact assets using evidence-based methods.
Next-generation AI simulates drug-patient outcomes so every clinical development decision is backed by evidence.
GitHubRepository owner
QuantHealth secures **$45 million** in funding to develop AI-driven simulations of clinical trials before their execution. The company aims to reduce the high failure rate—**90% of drugs** entering trials never reach market—by identifying potential issues early. This approach targets cost savings for pharmaceutical companies by mitigating late-stage failures.
Aug 2026MedCity NewsNews article
QuantHealth secures $45 million in Series B funding to deploy AI-driven simulations for clinical trials. The startup’s platform models trial outcomes before patient enrollment or costly development investments, having already simulated over 600 trials. Drugmakers use the technology to evaluate decisions and optimize trial design without incurring billions in upfront expenses.
Aug 2026CTechNews article
QuantHealth secures $45 million in Series B funding to expand its AI-powered platform for designing clinical trials through simulation-first approaches. The company leverages artificial intelligence to optimize trial development processes, aiming to enhance efficiency in healthcare research. This funding will drive broader adoption of its technology in the clinical trial industry.
Aug 2026Fierce HealthcareNews article
